To explore the fluctuations of Beclin1 and mTOR genes, and p62 markers across different clinicopathological parameters, the size of the tumor was classified as <5 cm or ≥5 cm, the grade was classified as low grade (including Grade I/low/well-differentiated & Grade II/intermediate/moderately differentiated) or high grade (including Grade III/high/poorly differentiated), and the stage was classified as low stage (IIA & IIB) or high stage (IIIA & IIIB). This evidence concerns the gene MTOR and neoplasm.